These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26944315)
1. Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression. Ma K; Xu Q; Wang S; Zhang W; Liu M; Liang S; Zhu H; Xu N Cancer Lett; 2016 May; 375(1):84-91. PubMed ID: 26944315 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma. Huo X; Zhang Q; Liu AM; Tang C; Gong Y; Bian J; Luk JM; Xu Z; Chen J Oncol Rep; 2013 Feb; 29(2):840-6. PubMed ID: 23232767 [TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels. Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045 [TBL] [Abstract][Full Text] [Related]
5. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Huang JM; Nagatomo I; Suzuki E; Mizuno T; Kumagai T; Berezov A; Zhang H; Karlan B; Greene MI; Wang Q Oncogene; 2013 Apr; 32(17):2220-9. PubMed ID: 22689061 [TBL] [Abstract][Full Text] [Related]
6. YAP/TEAD-mediated transcription controls cellular senescence. Xie Q; Chen J; Feng H; Peng S; Adams U; Bai Y; Huang L; Li J; Huang J; Meng S; Yuan Z Cancer Res; 2013 Jun; 73(12):3615-24. PubMed ID: 23576552 [TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53. Bai N; Zhang C; Liang N; Zhang Z; Chang A; Yin J; Li Z; Luo N; Tan X; Luo N; Luo Y; Xiang R; Li X; Reisfeld RA; Stupack D; Lv D; Liu C Cancer Biol Ther; 2013 Jun; 14(6):511-20. PubMed ID: 23760493 [TBL] [Abstract][Full Text] [Related]
8. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance. Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784 [TBL] [Abstract][Full Text] [Related]
9. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells. Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663 [TBL] [Abstract][Full Text] [Related]
10. Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice. Was H; Barszcz K; Czarnecka J; Kowalczyk A; Bernas T; Uzarowska E; Koza P; Klejman A; Piwocka K; Kaminska B; Sikora E Oncotarget; 2017 Feb; 8(6):9303-9322. PubMed ID: 28030837 [TBL] [Abstract][Full Text] [Related]
11. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells. Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641 [TBL] [Abstract][Full Text] [Related]
12. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents. Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051 [TBL] [Abstract][Full Text] [Related]
13. Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549/Taxol cells. Bai Z; Zhou Y; Ye X; Li Y; Peng Y; Guan Q; Zhang W; Ma L Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119174. PubMed ID: 34808206 [TBL] [Abstract][Full Text] [Related]
14. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells. Qin X; Li J; Sun J; Liu L; Chen D; Liu Y Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. Estève PO; Chin HG; Pradhan S J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180 [TBL] [Abstract][Full Text] [Related]
16. Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. Da CL; Xin Y; Zhao J; Luo XD World J Gastroenterol; 2009 Aug; 15(32):4055-61. PubMed ID: 19705503 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways. Wen Y; Ji Y; Zhang Y; Jiang B; Tang C; Wang Q; Chen X; Jia L; Gu W; Xu X Int J Med Sci; 2017; 14(12):1231-1240. PubMed ID: 29104479 [No Abstract] [Full Text] [Related]
18. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma. Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049 [TBL] [Abstract][Full Text] [Related]
19. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]